Titan Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
TRUIST FINANCIAL CORP | 02/02/2024 | 625,089 | $257,849 | 0.00% | 4.16% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 135,310 | $56,000 | -0.29% | 0.90% |
GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 87,945 | $29,022 | 0.00% | 0.59% |
VANGUARD GROUP INC | 03/11/2024 | 82,051 | $33,846 | 0.00% | 0.55% |
STATE STREET CORP | 02/14/2024 | 38,287 | $15,793 | 0.00% | 0.26% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2024 | 19,596 | $8,083 | -68.47% | 0.13% |
MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 15,113 | $6,234 | 100.00% | 0.10% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 1,544 | $638 | -1.84% | 0.01% |
LEVEL FINANCIAL ADVISORS, INC. | 01/23/2024 | 987 | $407 | 0.00% | 0.01% |
GROUP ONE TRADING, L.P. | 02/14/2024 | 230 | $95 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2024 | 207 | $85 | 0.49% | 0.00% |
JPMORGAN CHASE & CO | 12/26/2024 | 154 | $64 | -1.91% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/09/2024 | 89 | $37 | 5.95% | 0.00% |
BLACKROCK INC. | 02/13/2024 | 60 | $25 | 0.00% | 0.00% |
GLOBAL WEALTH STRATEGIES & ASSOCIATES | 01/02/2024 | 40 | $17,000 | 0.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 02/12/2024 | 37 | $13 | -26.00% | 0.00% |
WESTSIDE INVESTMENT MANAGEMENT, INC. | 01/12/2024 | 4 | $2 | 0.00% | 0.00% |
NEWEDGE ADVISORS, LLC | 02/13/2024 | 4 | $2 | 100.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/13/2024 | 4 | $2 | 0.00% | 0.00% |
MORGAN STANLEY | 08/16/2024 | 3 | $1 | -81.25% | 0.00% |
UBS GROUP AG | 02/09/2024 | 2 | $1 | -50.00% | 0.00% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 03/28/2024 | 2 | $1 | 0.00% | 0.00% |
FMR LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
CALDWELL SUTTER CAPITAL, INC. | 01/19/2024 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
NEMES RUSH GROUP LLC | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
Titan Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Titan Pharmaceuticals, Inc.. The most heavily invested institutionals were:
American Portfolios Advisors: 23
6.70% of Titan Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 23 shares in the last 24 months. This purchase volume represents approximately $75 in transactions.